NTLA-3001

· Intellia Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NTLA-3001, covering 2025-01-17 to 2025-01-17. Get the full timeline:

Most recent: Clinical Trial Update: NTLA-3001 in Adults with Alpha-1 Antitrypsin Deficiency-Associated Lung Disease [Phase 1, Phase 2]